Failure of erythromycin to improve chloroquine treatment of Plasmodium falciparum malaria in Kenya

Trans R Soc Trop Med Hyg. 1988;82(3):363-5. doi: 10.1016/0035-9203(88)90119-8.

Abstract

58 children aged 1 to 10 years who had pure Plasmodium falciparum infections acquired on the coast of Kenya were treated with chloroquine 25 mg/kg given over 3 d and erythromycin 10 mg/kg 4 times a day given for 7 d. After 4 weeks follow-up, 62% had recurrent infections and 11% failed to clear their parasitaemia (1 had an RIII pattern of resistance). Of 38 children treated with chloroquine 25 mg/kg alone, 55% had recurrences and 21% failed to clear (including 1 RIII). In vitro microtests classified 74% of isolates from initial infections and 91% of isolates from recurrent infections as resistant. Erythromycin does not improve chloroquine treatment in children with infections due to P. falciparum having low to moderate levels of chloroquine resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Child
  • Child, Preschool
  • Chloroquine / therapeutic use*
  • Drug Therapy, Combination
  • Erythromycin / therapeutic use*
  • Humans
  • Infant
  • Kenya
  • Malaria / drug therapy*
  • Plasmodium falciparum

Substances

  • Erythromycin
  • Chloroquine